SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-054503
Filing Date
2019-10-30
Accepted
2019-10-30 16:16:51
Documents
1
Period of Report
2019-10-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6480
  Complete submission text file 0001209191-19-054503.txt   7891
Mailing Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080 (650) 416-7700
Principia Biopharma Inc. (Issuer) CIK: 0001510487 (see all company filings)

IRS No.: 263487603 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O NEW LEAF VENTURE PARTNERS TIMES SQ TOWER, 7 TIMES SQ, STE 3502 NEW YORK NY 10036
Business Address
Becker Daniel J. (Reporting) CIK: 0001752139 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38653 | Film No.: 191180322